作为一个致癌枢纽,ACTL6A的新兴作用:转录调节和超越
Kelvin K Tsai1, Li-Hsin Cheng2, Chung-Chi Hsu3
1National Health Research Institutes, Taipei City, Taiwan.
Molecular cancer research : MCR
|April 7, 2025
概括
类似动蛋白6A (ACTL6A) 是一个关键的癌症中心,在许多癌症中过度表达. 它通过多种机制驱动恶性进展,为新的癌症诊断和治疗提供了潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 癌症的进展是由协调信号通路的监管枢纽驱动的.
- 识别这些致癌中心对于开发新型癌症疗法至关重要.
- 类似于动氨酸的6A (ACTL6A),是一种染色质重塑因子,与基因调节有关.
研究的目的:
- 审查ACTL6A在人类癌症进展中的多种作用.
- 要总结ACTL6A的表达,预后意义和调控机制.
- 突出ACTL6A作为治疗标和诊断标记物的潜力.
主要方法:
- 对人类癌症中ACTL6A研究的文献综述.
- 分析ACTL6A的表达模式和预后价值.
- 检查超出转录调节的ACTL6A的非正规功能.
主要成果:
- 在大多数人类癌症中,ACTL6A过度表达,与恶性表型相关.
- ACTL6A促进细胞循环的进展,癌症干,EMT和代谢重编程.
- ACTL6A可以稳定型蛋白和干性因子,如YAP,VPS72和MYC.
结论:
- ACTL6A作为癌症干细胞和进展中的类调节枢纽.
- 了解ACTL6A的多种机制对于癌症治疗的发展至关重要.
- ACTL6A对分子知情诊断和改善患者治疗结果具有前景.
更多相关视频
10:32Combined Use of Tail Vein Metastasis Assays and Real-Time In Vivo Imaging to Quantify Breast Cancer Metastatic Colonization and Burden in the Lungs
Published on: December 20, 2019
10.4K
07:38Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
960
相关概念视频
Eukaryotic Transcription Activators
10.8K
Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
10.8K
Master Transcription Regulators
6.8K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.8K
lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
General Transcription Factors
5.1K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.1K
